Skip to main content
. 2019 Apr 29;14:893–903. doi: 10.2147/COPD.S185837

Table 2.

Survival associated with preexisting COPD among elderly patients with NSCLC

Group Total Dead Alive censored Percent Median
Alive (Days)
Stage I NSCLC
Non-COPD 7,184 3,726 3,458 48.13 1,130
COPD 4,835 3,220 1,615 33.4 692
Emphysema 766 473 293 38.25 811
Chronic bronchitis 2,402 1,640 762 31.72 672
Stage II NSCLC
Non-COPD 2,282 1,701 581 25.46 627
COPD 1,123 916 207 18.43 473
Emphysema 171 125 46 26.9 582
Chronic bronchitis 539 446 93 17.25 445
Stage III NSCLC
Non-COPD 10,097 9,029 1,068 10.58 255
COPD 5,315 4,889 426 8.02 224
Emphysema 789 719 70 8.87 229
Chronic bronchitis 2,717 2,522 195 7.18 222
Stage IV NSCLC
Non-COPD 19,675 19,134 541 2.75 112
COPD 8,176 8,003 173 2.12 106
Emphysema 1,398 1,365 33 2.36 110
Chronic bronchitis 4,116 4,041 75 1.82 105

Abbreviation: NSCLC, non-small-cell lung cancer